• 8035 Citations
  • 32 h-Index
20052020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2005 2020

Filter
Article
2020

Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer

Gerber, D. E., Camidge, D. R., Morgensztern, D., Cetnar, J., Kelly, R. J., Ramalingam, S. S., Spigel, D. R., Jeong, W., Scaglioni, P. P., Zhang, S., Li, M., Weaver, D. T., Vaikus, L., Keegan, M., Horobin, J. C. & Burns, T. F., Jan 2020, In : Lung Cancer. 139, p. 60-67 8 p.

Research output: Contribution to journalArticle

Focal Adhesion Kinase 2
Non-Small Cell Lung Carcinoma
Disease-Free Survival
Focal Adhesion Protein-Tyrosine Kinases
Bilirubin
2019

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer

Wang, T., Lu, R., Lai, S., Schiller, J. H., Zhou, F. L., Ci, B., Wang, S., Gao, X., Yao, B., Gerber, D. E., Johnson, D. H., Xiao, G. & Xie, Y., Apr 1 2019, In : Cancer Informatics. 18

Research output: Contribution to journalArticle

Open Access
Nomograms
Non-Small Cell Lung Carcinoma
ROC Curve
Neoplasm Metastasis
Survival

Increasing Numbers and Reported Adverse Events in Patients with Lung Cancer Undergoing Inpatient Lung Biopsies: A Population-Based Analysis

von Itzstein, M. S., Gupta, A., Mara, K. C., Khanna, S. & Gerber, D. E., Oct 1 2019, In : Lung. 197, 5, p. 593-599 7 p.

Research output: Contribution to journalArticle

Patient Safety
Inpatients
Lung Neoplasms
Biopsy
Lung
1 Citation (Scopus)

Mobile Device Applications for Electronic Patient Portals in Oncology

Pho, K. K., Lu, R., Gates, S., Cai, J., Xie, D., Xie, Y., Lee, S. C. & Gerber, D. E., Feb 1 2019, In : JCO clinical cancer informatics. 3, p. 1-8 8 p.

Research output: Contribution to journalArticle

Mobile Applications
Equipment and Supplies
Patient Portals
Technology
Electronic Health Records
1 Citation (Scopus)

NQO1-dependent, tumor-selective radiosensitization of non-small cell lung cancers

Motea, E. A., Huang, X., Singh, N., Kilgore, J. A., Williams, N. S., Xie, X-J., Gerber, D. E., Beg, M. S., Bey, E. A. & Boothman, D. A., Apr 15 2019, In : Clinical Cancer Research. 25, 8, p. 2601-2609 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
NAD
Neoplasms
Pharmacokinetics
Adenosine Triphosphate
1 Citation (Scopus)
Mouth Neoplasms
Interviews
Safety-net Providers
Tertiary Care Centers
Therapeutics

Stakeholder engagement to initiate lung cancer screening in an urban safety-net health system

Lee, S. J. C., Hamann, H. A., Browning, T., Santini, N. O., Abbara, S., Balis, D. S., Chiu, H., Moran, B. A., McGuire, M. & Gerber, D. E., Jan 1 2019, (Accepted/In press) In : Healthcare. 100370.

Research output: Contribution to journalArticle

Early Detection of Cancer
Lung Neoplasms
Guidelines
Safety
Patient Participation

Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non–small cell lung cancer

Wang, S., Lai, S., von Itzstein, M. S., Yang, L., Yang, D. M., Zhan, X., Xiao, G., Halm, E. A., Gerber, D. E. & Xie, Y., Jan 1 2019, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Health Facilities
Non-Small Cell Lung Carcinoma
Delivery of Health Care
Neoplasms
Logistic Models
2 Citations (Scopus)

Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling

Khan, S., Ci, B., Xie, Y., Gerber, D. E., Beg, M. S., Sherman, S. I., Cabanillas, M. E., Busaidy, N. L., Burtness, B. A., Heilmann, A. M., Bailey, M., Ross, J. S., Sher, D. J. & Ali, S. M., Jan 1 2019, In : Head and Neck.

Research output: Contribution to journalArticle

Mutation
Neoplasm Genes
Thyroid Neoplasms
Anaplastic Thyroid Carcinoma
Therapeutics

Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors

Hsiehchen, D., Watters, M. K., Lu, R., Xie, Y. & Gerber, D. E., Sep 4 2019, In : JAMA network open. 2, 9, p. e1911519

Research output: Contribution to journalArticle

Open Access
Poisons
Hypothyroidism
Immunotherapy
Cell Death
Odds Ratio
2018
143 Citations (Scopus)
Maintenance Chemotherapy
Non-Small Cell Lung Carcinoma
Radiotherapy
Randomized Controlled Trials
Disease-Free Survival
4 Citations (Scopus)

Development and Validation of a Nomogram Prognostic Model for SCLC Patients

Wang, S., Yang, L., Ci, B., Maclean, M., Gerber, D. E., Xiao, G. & Xie, Y., Sep 1 2018, In : Journal of Thoracic Oncology. 13, 9, p. 1338-1348 11 p.

Research output: Contribution to journalArticle

Nomograms
Neoplasm Staging
Area Under Curve
Neoplasms
ROC Curve
1 Citation (Scopus)

Estimating lead-time bias in lung cancer diagnosis of patients with previous cancers

Ge, Z., Heitjan, D. F., Gerber, D. E., Xuan, L. & Pruitt, S. L., Jan 1 2018, (Accepted/In press) In : Statistics in Medicine.

Research output: Contribution to journalArticle

Lung Cancer
Lung Neoplasms
Cancer
Survival
Neoplasms
5 Citations (Scopus)
Medicare
Autoimmune Diseases
Lung Neoplasms
Epidemiology
Neoplasms
6 Citations (Scopus)

Immune dysregulation in cancer patients developing immune-related adverse events

Khan, S., Khan, S., Luo, X., Fattah, F. J., Saltarski, J., Gloria-McCutchen, Y., Lu, R., Xie, Y., Li, Q., Wakeland, E. K. & Gerber, D. E., Jan 1 2018, (Accepted/In press) In : British Journal of Cancer.

Research output: Contribution to journalArticle

Neoplasms
Cytokines
Therapeutics
Interleukin-10
Serum
2 Citations (Scopus)

Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysis

Yang, L., Wang, S., Gerber, D. E., Zhou, Y., Xu, F., Liu, J., Liang, H., Xiao, G., Zhou, Q., Gazdar, A. & Xie, Y., Jun 1 2018, In : Lung Cancer. 120, p. 22-26 5 p.

Research output: Contribution to journalArticle

Bronchi
Cohort Studies
Neoplasm Metastasis
Adenocarcinoma
Adenocarcinoma of lung
21 Citations (Scopus)

Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC

Gettinger, S., Hellmann, M. D., Chow, L. Q. M., Borghaei, H., Antonia, S., Brahmer, J. R., Goldman, J. W., Gerber, D. E., Juergens, R. A., Shepherd, F. A., Laurie, S. A., Young, T. C., Li, X., Geese, W. J. & Rizvi, N., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

Protein-Tyrosine Kinases
Mutation
Erlotinib Hydrochloride
nivolumab
Research Personnel
3 Citations (Scopus)

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis

Gerber, D. E., Beg, M. S., Fattah, F., Frankel, A. E., Fatunde, O., Arriaga, Y., Dowell, J. E., Bisen, A., Leff, R. D., Meek, C. C., Putnam, W. C., Kallem, R. R., Subramaniyan, I., Dong, Y., Bolluyt, J., Sarode, V., Luo, X., Xie, Y., Schwartz, B. & Boothman, D. A., Oct 16 2018, In : British Journal of Cancer. 119, 8, p. 928-936 9 p.

Research output: Contribution to journalArticle

Necrosis
Neoplasms
Methemoglobinemia
Anemia
Oxidoreductases
21 Citations (Scopus)
SEER Program
Neoplasms
Clinical Trials
Survivors
4 Citations (Scopus)

Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer

Gerber, D. E., Socinski, M. A., Neal, J. W., Wakelee, H. A., Shirai, K., Sequist, L. V., Rosovsky, R. P., Lilenbaum, R. C., Bastos, B. R., Huang, C., Johnson, M. L., Hesketh, P. J., Subramaniam, D. S., Dietrich, M. F., Chai, F., Wang, Y., Kazakin, J., Schwartz, B., Schiller, J. H., Brahmer, J. R. & 1 others, Kelly, R. J., Mar 1 2018, In : Lung Cancer. 117, p. 44-49 6 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Disease-Free Survival
Drug Therapy
docetaxel
gemcitabine
5 Citations (Scopus)

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

Gerber, D. E., Horn, L., Boyer, M., Sanborn, R., Natale, R., Palmero, R., Bidoli, P., Bondarenko, I., Germonpre, P., Ghizdavescu, D., Kotsakis, A., Lena, H., Losonczy, G., Park, K., Su, W. C., Tang, M., Lai, J., Kallinteris, N. L., Shan, J. S., Reck, M. & 1 others, Spigel, D. R., Jul 1 2018, In : Annals of Oncology. 29, 7, p. 1548-1553 6 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Survival
Glycoproteins
Placebos
8 Citations (Scopus)

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy

Mohamad, O., Diaz de Leon, A., Schroeder, S., Leiker, A., Christie, A., Zhang-Velten, E., Trivedi, L., Khan, S., Desai, N. B., Laine, A., Albuquerque, K., Iyengar, P., Arriaga, Y., Courtney, K., Gerber, D. E., Hammers, H., Choy, H., Timmerman, R., Brugarolas, J. & Hannan, R., Mar 10 2018, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journalArticle

Radiotherapy
Safety
Disease-Free Survival
Fatigue
Melanoma
1 Citation (Scopus)

Statistical justification of expansion cohorts in phase 1 cancer trials

Mokdad, A. A., Xie, X. J., Zhu, H., Gerber, D. E. & Heitjan, D. F., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Investigational Drugs
Maximum Tolerated Dose
Safety
Pharmaceutical Preparations
Sample Size
10 Citations (Scopus)

TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer

Gong, K., Guo, G., Gerber, D. E., Gao, B., Peyton, M., Huang, C., Minna, J. D., Hatanpaa, K. J., Kernstine, K., Cai, L., Xie, Y., Zhu, H., Fattah, F. J., Zhang, S., Takahashi, M., Mukherjee, B., Burma, S., Dowell, J., Dao, K., Papadimitrakopoulou, V. A. & 4 others, Olivas, V., Bivona, T. G., Zhao, D. & Habib, A. A., Jun 1 2018, In : Journal of Clinical Investigation. 128, 6, p. 2500-2518 19 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Lung Neoplasms
RNA Stability
Inflammation Mediators
Oncogenes
Mesothelioma
Survival
Drug Therapy
Pemetrexed
Neoplasm Metastasis
2017
7 Citations (Scopus)

A phase ib dose-escalation study of the safety, tolerability, and pharmacokinetics of cobimetinib and duligotuzumab in patients with previously treated locally advanced ormetastatic cancers with mutant KRAS

Lieu, C. H., Hidalgo, M., Berlin, J. D., Ko, A. H., Cervantes, A., LoRusso, P., Gerber, D. E., Paul Eder, J., Gail Eckhardt, S., Kapp, A. V., Tsuhako, A., McCall, B., Pirzkall, A., Uyei, A. & Tabernero, J., Sep 1 2017, In : Oncologist. 22, 9

Research output: Contribution to journalArticle

Pharmacokinetics
Safety
Epidermal Growth Factor Receptor
Neoplasms
Mitogen-Activated Protein Kinases
2 Citations (Scopus)

Cancer center clinic and research team perceptions of identity and interactions

Reimer, T., Lee, S. J. C., Garcia, S., Gill, M., Duncan, T., Williams, E. L. & Gerber, D. E., Dec 1 2017, In : Journal of Oncology Practice. 13, 12, p. e1021-e1029

Research output: Contribution to journalArticle

Research
Neoplasms
National Cancer Institute (U.S.)
Climate
Analysis of Variance
7 Citations (Scopus)

Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition

Le, T., Sailors, J., Oliver, D. H., Mayer, M., Hoskin, S. & Gerber, D. E., Mar 1 2017, In : Lung Cancer. 105, p. 14-16 3 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Phosphotransferases
Adenocarcinoma of lung
391 Citations (Scopus)

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

Hellmann, M. D., Rizvi, N. A., Goldman, J. W., Gettinger, S. N., Borghaei, H., Brahmer, J. R., Ready, N. E., Gerber, D. E., Chow, L. Q., Juergens, R. A., Shepherd, F. A., Laurie, S. A., Geese, W. J., Agrawal, S., Young, T. C., Li, X. & Antonia, S. J., Jan 1 2017, In : The Lancet Oncology. 18, 1, p. 31-41 11 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Therapeutics
ipilimumab
nivolumab
Safety
1 Citation (Scopus)

Oncology nursing perceptions of patient electronic portal use: A qualitative analysis

Gerber, D. E., Beg, M. S., Duncan, T., Gill, M. & Lee, S. J. C., Mar 1 2017, In : Oncology Nursing Forum. 44, 2, p. 165-170 6 p.

Research output: Contribution to journalArticle

Oncology Nursing
Patient Safety
Nursing Staff
Workload
Technology
5 Citations (Scopus)

Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trial

Gerber, D. E., Hamann, H. A., Santini, N. O., Abbara, S., Chiu, H., McGuire, M., Quirk, L., Zhu, H. & Lee, S. J. C., Sep 1 2017, In : Contemporary Clinical Trials. 60, p. 78-85 8 p.

Research output: Contribution to journalArticle

Patient Navigation
Pragmatic Clinical Trials
Early Detection of Cancer
Lung Neoplasms
Randomized Controlled Trials
5 Citations (Scopus)

Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers

Yu, H. A., Ahn, M. J., Cho, B. C., Gerber, D. E., Natale, R. B., Socinski, M. A., Giri, N., Quinn, S., Sbar, E., Zhang, H. & Giaccone, G., Oct 1 2017, In : Lung Cancer. 112, p. 195-199 5 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Epidermal Growth Factor Receptor
Disease-Free Survival
Paronychia
Stomatitis
5 Citations (Scopus)

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Gerber, D. E., Swanson, P., Lopez-Chavez, A., Wong, L., Dowlati, A., Pennell, N. A., Cronier, D. M., Qin, A., Ilaria, R., Cosaert, J., Shahir, A. & Baggstrom, M. Q., Sep 1 2017, In : Lung Cancer. 111, p. 108-115 8 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Non-Small Cell Lung Carcinoma
Platelet-Derived Growth Factor Receptors
olaratumab
17 Citations (Scopus)

Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer

Pruitt, S. L., Laccetti, A. L., Xuan, L., Halm, E. A. & Gerber, D. E., Feb 14 2017, (Accepted/In press) In : British Journal of Cancer.

Research output: Contribution to journalArticle

Lung Neoplasms
Clinical Trials
Neoplasms
Propensity Score
Survival
6 Citations (Scopus)

Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer

Gupta, A., Saltarski, J. M., White, M. A., Scaglioni, P. P. & Gerber, D. E., Sep 1 2017, In : Journal of Thoracic Oncology. 12, 9, p. 1446-1450 5 p.

Research output: Contribution to journalArticle

Cell Nucleus Active Transport
Lung Neoplasms
Tumor Suppressor Proteins
Cell Cycle
Proteinase-Activated Receptors
9 Citations (Scopus)

Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity

Garcia, S., Bisen, A., Yan, J., Xie, X. J., Ramalingam, S., Schiller, J. H., Johnson, D. H. & Gerber, D. E., Oct 1 2017, In : Journal of Thoracic Oncology. 12, 10, p. 1489-1495 7 p.

Research output: Contribution to journalArticle

Thorax
Clinical Trials
Lung Neoplasms
Therapeutics
Hematologic Tests
5 Citations (Scopus)

Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical Trials

Garcia, S., Saltarski, J. M., Yan, J., Xie, X. J. & Gerber, D. E., Feb 28 2017, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Lung Neoplasms
Clinical Trials
Communication
Biomarkers
Therapeutics

Upper lip metastasis of sarcomatoid carcinoma of the lung - An unusual site of disease: A case report

Le, T., Mayer, M., Sailors, J., Gerber, D. E. & Truelson, J. M., Jan 19 2017, In : Journal of Medical Case Reports. 11, 1, 18.

Research output: Contribution to journalArticle

Lip
Neoplasm Metastasis
Carcinoma
Lung
Skin
9 Citations (Scopus)

Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer

Beg, M. S., Huang, X., Silvers, M. A., Gerber, D. E., Bolluyt, J., Sarode, V., Fattah, F., Deberardinis, R. J., Merritt, M. E., Xie, X. J., Leff, R., Laheru, D. & Boothman, D. A., 2017, (Accepted/In press) In : Journal of Surgical Oncology.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Catalase
Pharmaceutical Preparations
Neoplasms
Substrate Cycling
2016
39 Citations (Scopus)

Acquired resistance to first-line afatinib and the challenges of prearranged progression biopsies

Campo, M., Gerber, D., Gainor, J. F., Heist, R. S., Temel, J. S., Shaw, A. T., Fidias, P., Muzikansky, A., Engelman, J. A. & Sequist, L. V., Nov 13 2016, In : Journal of Thoracic Oncology. 11, 11, p. 2022-2026 5 p.

Research output: Contribution to journalArticle

Biopsy
Confidence Intervals
Mutation
BIBW 2992
Protein-Tyrosine Kinases
9 Citations (Scopus)

Axl receptor axis: A new therapeutic target in lung cancer

Levin, P. A., Brekken, R. A., Byers, L. A., Heymach, J. V. & Gerber, D. E., 2016, In : Journal of Thoracic Oncology. 11, 8, p. 1357-1362 6 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Therapeutics
1 Citation (Scopus)

Choroid plexus papilloma-A case highlighting the challenges of extrapolating pediatric chemotherapy regimens to adult populations

Barman, S. L., Jean, G. W., Dinsfriend, W. M. & Gerber, D. E., Feb 1 2016, In : Journal of Oncology Pharmacy Practice. 22, 1, p. 170-174 5 p.

Research output: Contribution to journalArticle

Choroid Plexus Papilloma
Pediatrics
Drug Therapy
Population
Intercellular Signaling Peptides and Proteins
8 Citations (Scopus)

Docetaxel Combined with Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung Cancer

Gerber, D. E., Spigel, D. R., Giorgadze, D., Shtivelband, M., Ponomarova, O. V., Shan, J. S., Menander, K. B. & Belani, C. P., May 1 2016, In : Clinical Lung Cancer. 17, 3, p. 169-176 8 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Confidence Intervals
Placebos
bavituximab
11 Citations (Scopus)

Increase in cancer center staff effort related to electronic patient portal use

Laccetti, A. L., Chen, B., Cai, J., Gates, S., Xie, Y., Lee, S. J. C. & Gerber, D. E., Dec 1 2016, In : Journal of Oncology Practice. 12, 12, p. e981-e990

Research output: Contribution to journalArticle

Personal Health Records
Nurses
Neoplasms
Technology
Physicians
33 Citations (Scopus)

Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors

Huang, X., Motea, E. A., Moore, Z. R., Yao, J., Dong, Y., Chakrabarti, G., Kilgore, J. A., Silvers, M. A., Patidar, P. L., Cholka, A., Fattah, F., Cha, Y., Anderson, G. G., Kusko, R., Peyton, M., Yan, J., Xie, X. J., Sarode, V., Williams, N. S., Minna, J. D. & 4 others, Beg, M., Gerber, D. E., Bey, E. A. & Boothman, D. A., Dec 12 2016, In : Cancer Cell. 30, 6, p. 940-952 13 p.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Neoplasms
Poly(ADP-ribose) Polymerases
Recycling
Caspases
1 Citation (Scopus)

Next-Generation Sequencing for the Identification of Targetable Molecular Alterations in Cancer

Dietrich, M. F., Collins, R. H. & Gerber, D. E., Jan 1 2016, In : JAMA oncology. 2, 1, p. 132-133 2 p.

Research output: Contribution to journalArticle

Neoplasm Drug Resistance
DNA Mutational Analysis
Pyrazoles
Molecular Targeted Therapy
Predictive Value of Tests
217 Citations (Scopus)

Nivolumab in combination with platinum-based doublet chemotherapy for first-line treatment of advanced non-small-cell lung cancer

Rizvi, N. A., Hellmann, M. D., Brahmer, J. R., Juergens, R. A., Borghaei, H., Gettinger, S., Chow, L. Q., Gerber, D. E., Laurie, S. A., Goldman, J. W., Shepherd, F. A., Chen, A. C., Shen, Y., Nathan, F. E., Harbison, C. T. & Antonia, S., Sep 1 2016, In : Journal of Clinical Oncology. 34, 25, p. 2969-2979 11 p.

Research output: Contribution to journalArticle

Platinum
Non-Small Cell Lung Carcinoma
Drug Therapy
Carboplatin
gemcitabine
227 Citations (Scopus)

Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer

Gettinger, S., Rizvi, N. A., Chow, L. Q., Borghaei, H., Brahmer, J., Ready, N., Gerber, D. E., Shepherd, F. A., Antonia, S., Goldman, J. W., Juergens, R. A., Laurie, S. A., Nathan, F. E., Shen, Y., Harbison, C. T. & Hellmann, M. D., Sep 1 2016, In : Journal of Clinical Oncology. 34, 25, p. 2980-2987 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Disease-Free Survival
Survival Rate
docetaxel
Exanthema
31 Citations (Scopus)

Prevalence of Autoimmune Disease Among Patients With Lung Cancer: Implications for Immunotherapy Treatment Options

Khan, S. A., Pruitt, S. L., Xuan, L. & Gerber, D. E., Nov 1 2016, In : JAMA oncology. 2, 11, p. 1507-1508 2 p.

Research output: Contribution to journalArticle

Immunotherapy
Autoimmune Diseases
Lung Neoplasms
Therapeutics
14 Citations (Scopus)

Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis

Laccetti, A. L., Pruitt, S. L., Xuan, L., Halm, E. A. & Gerber, D. E., Aug 1 2016, In : Lung Cancer. 98, p. 106-113 8 p.

Research output: Contribution to journalArticle

Medicare
Lung Neoplasms
Survival
Neoplasms
Propensity Score